The Access for ALL in ALS (ALL ALS) Consortium is a nationwide, NIH-funded clinical research initiative in the United States that collects and shares biological samples and clinical data to accelerate amyotrophic lateral sclerosis (ALS) research.  Aeryn Hopwood and Emma Schmidt of the Les Turner ALS Center at Northwestern Medicine will discuss the structure of the study including the study cohorts, the inclusion/exclusion criteria, which cohorts are still enrolling, the different sites located across the United States, the importance of identifying biomarkers in ALS, what the goals of the studies are, and what data the consortium is collecting actively that will help people living with ALS, their family members, and others in the future.   

The Les Turner ALS Foundation is proud to offer this webinar at no cost to the ALS community. Thank you to Biogen & Shionogi for sponsoring this webinar.